LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,649,952 | +1.5% | 352,091 | +4.3% | 0.14% | -0.7% |
| Q2 2023 | $23,296,590 | +73.2% | 337,485 | +21.0% | 0.14% | +75.6% |
| Q1 2023 | $13,450,583 | -40.6% | 278,942 | -38.5% | 0.08% | -33.9% |
| Q4 2022 | $22,644,860 | -10.1% | 453,623 | -26.5% | 0.12% | -3.1% |
| Q3 2022 | $25,188,000 | -19.9% | 617,350 | +8.0% | 0.13% | -3.8% |
| Q2 2022 | $31,437,000 | +59.3% | 571,587 | +5.2% | 0.13% | +66.2% |
| Q1 2022 | $19,740,000 | +264.6% | 543,206 | +367.6% | 0.08% | +158.1% |
| Q4 2021 | $5,414,000 | – | 116,159 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
| Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
| HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
| Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
| Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
| AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
| Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
| Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |